Premier News

Our recent announcements and latest news

Data Management & Biostatistics

Premier Research Vice President, Statistical Consulting, Recognized by AMSTAT for Black History Month

DURHAM, N.C., February 1, 2021 — Premier Research, the clinical research company that delivers outcome-focused insights which support sponsors in developing life-changing therapies, announced today that Abie Ekangaki, Ph.D., Vice President, Statistical Consulting, has been recognized by the American Statistical Association (AMSTAT) in celebration of Black History Month. Dr. Ekangaki is one of ten Black...

Clinical Research: Phase 1 - Phase 4

Premier Research to Present on Development Considerations for Advanced Therapies at LSX World Congress

DURHAM, N.C., January 25, 2021 — Premier Research, the clinical research company that delivers outcome-focused insights which support sponsors in developing life-changing therapies, will join the healthcare and life science industries’ most forward-thinking executives at the LSX World Congress virtual conference from February 1 to 5, 2021. The conference will include a presentation by Premier...

Clinical Research: Phase 1 - Phase 4

Drug and Device Development Secrets in the World of Medical Aesthetics, Upcoming Webinar

TORONTO (PRWEB) NOVEMBER 09, 2020 New treatment options for aesthetic indications are in record-high demand, fueled by an aging population, and a growing focus on aesthetic issues related to nutritional habits, sedentary lifestyles, the complex stresses of 21st-century life and rising awareness about aesthetic solutions in all adult age groups. The search for more effective,...

Clinical Research: Phase 1 - Phase 4

The Importance of Site Selection and Dosing Strategies in Early-Phase Oncology Studies

TORONTO (PRWEB) NOVEMBER 02, 2020 Setting up an effective phase 1 trial for a novel investigational oncology product is rife with challenges. Every aspect, from site identification to estimation and coordination of enrollment and safety review, is interrelated to ensure a timely dose determination that is nimble and allows flexibility. What factors can affect, or...

Clinical Research: Phase 1 - Phase 4

mHealth and Remote Clinical Trial Strategies to Include in Your Next Study, Upcoming Webinar

TORONTO, ONTARIO (PRWEB) OCTOBER 01, 2020 What happens when patients and clinical research associates alike can’t—or won’t — go to your clinical trial sites? It’s time for a new plan. In the months since the novel coronavirus brought all normal activity to a halt, clinical trials worldwide have been forced to re-examine their strategies and...

Clinical Research: Phase 1 - Phase 4

Achieving the Promise of Gene Therapy: New Pathways to Overcome Patient Enrollment and Safety Challenges, Upcoming Webinar

TORONTO (PRWEB) SEPTEMBER 15, 2020 Though gene therapy has been around for decades, it continues to pose extraordinary challenges in the areas of R&D, clinical development, and operation of clinical trials. Sponsors and CROs face shifting operational and regulatory demands amid rapid advances in the science of precision medicine. This webinar will examine the evolving...